Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Concordance analysis between HER2 immunohistochemistry and in situ hybridization in non-small cell lung cancer.

The International journal of biological markers - 1 Jan 2018

Ko Young San, Kim Nae Yu, Pyo Jung-Soo

Abstract excerpt

PURPOSE: This study aimed to elucidate the concordance between human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) and in situ hybridization (ISH) and the diagnostic accuracy of HER2 IHC in non-small cell lung cancer (NSCLC) through a meta-analysis and diagnostic test accuracy review. METHODS: Seven eligible studies and 1,217 patients with NSCLC were included in the review. The concordance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Diagnostic Tests, Routine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to In Situ Hybridization

Share to Mutation

Share to Receptor, ErbB-2

Source

Identifiers

PMID: 28478639
DOI: 10.5301/ijbm.5000271

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Concordance analysis between HER2 immunohistochemistry and in situ hybridization in non-small cell lung cancer.PMID 28478639Read ↗

HER2 status in lung adenocarcinoma: a comparison of immunohistochemistry, fluorescence in situ hybridization (FISH), dual-ISH, and gene mutations.Semantic proximity Read ↗

High Concordance Between Two Companion Diagnostics TestsSemantic proximity Read ↗

Improving Selection Criteria for ALK Inhibitor Therapy in Non-Small Cell Lung Cancer: A Pooled-Data Analysis on Diagnostic Operating Characteristics of Immunohistochemistry.Semantic proximity Read ↗

NTRK, RET, ROS1, and ALK Gene Fusion in HER2 Immunohistochemistry 2+ Breast CarcinomaSemantic proximity Read ↗

Concordance of Immunohistochemistry and Fluorescence In Situ Hybridization in the Detection of Anaplastic Lymphoma Kinase (ALK) and Ros Proto-oncogene 1 (ROS1) Gene Rearrangements in Non-Small Cell Lung Carcinoma: A 4.5-Year Experience Highlighting Challenges and Pitfalls.Semantic proximity Read ↗

[Immunohistochemical detections of EGFR status in NSCLC].Semantic proximity Read ↗

Diagnostic Accuracy of BRAF Immunohistochemistry in Colorectal Cancer: a Meta-Analysis and Diagnostic Test Accuracy Review.Semantic proximity Read ↗

Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencingSemantic proximity Read ↗

[Influence of Immunohistochemistry Scoring Criteria in Detecting EGFR Mutations].Semantic proximity Read ↗

Roles of immunohistochemical staining in diagnosing pulmonary squamous cell carcinoma.Semantic proximity Read ↗

Human Epidermal Growth Factor Receptor-2(HER-2) expression in Sri Lankan gastric adenocarcinoma patients: An analysis of the concordance of HER2 expression and survival based on silver in-situ hybridization (SISH)Semantic proximity Read ↗

[Value of Immunohistochemical Methods in Detecting EML4-ALK Fusion Mutations: A Meta-analysis].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.